Cargando…
Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase
Heparan Sulfate (HS) is a cell signaling molecule linked to pathological processes ranging from cancer to viral entry, yet fundamental aspects of its biosynthesis remain incompletely understood. Here, the binding preferences of the uronyl 2-O-sulfotransferase (HS2ST) are examined with variably-sulfa...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081452/ https://www.ncbi.nlm.nih.gov/pubmed/30087361 http://dx.doi.org/10.1038/s41598-018-29602-4 |
_version_ | 1783345652857569280 |
---|---|
author | Thieker, David F. Xu, Yongmei Chapla, Digantkumar Nora, Chelsea Qiu, Hong Felix, Thomas Wang, Lianchun Moremen, Kelley W. Liu, Jian Esko, Jeffrey D. Woods, Robert J. |
author_facet | Thieker, David F. Xu, Yongmei Chapla, Digantkumar Nora, Chelsea Qiu, Hong Felix, Thomas Wang, Lianchun Moremen, Kelley W. Liu, Jian Esko, Jeffrey D. Woods, Robert J. |
author_sort | Thieker, David F. |
collection | PubMed |
description | Heparan Sulfate (HS) is a cell signaling molecule linked to pathological processes ranging from cancer to viral entry, yet fundamental aspects of its biosynthesis remain incompletely understood. Here, the binding preferences of the uronyl 2-O-sulfotransferase (HS2ST) are examined with variably-sulfated hexasaccharides. Surprisingly, heavily sulfated oligosaccharides formed by later-acting sulfotransferases bind more tightly to HS2ST than those corresponding to its natural substrate or product. Inhibition assays also indicate that the IC(50) values correlate simply with degree of oligosaccharide sulfation. Structural analysis predicts a mode of inhibition in which 6-O-sulfate groups located on glucosamine residues present in highly-sulfated oligosaccharides occupy the canonical binding site of the nucleotide cofactor. The unexpected finding that oligosaccharides associated with later stages in HS biosynthesis inhibit HS2ST indicates that the enzyme must be separated temporally and/or spatially from downstream products during biosynthesis in vivo, and highlights a challenge for the enzymatic synthesis of lengthy HS chains in vitro. |
format | Online Article Text |
id | pubmed-6081452 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-60814522018-08-10 Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase Thieker, David F. Xu, Yongmei Chapla, Digantkumar Nora, Chelsea Qiu, Hong Felix, Thomas Wang, Lianchun Moremen, Kelley W. Liu, Jian Esko, Jeffrey D. Woods, Robert J. Sci Rep Article Heparan Sulfate (HS) is a cell signaling molecule linked to pathological processes ranging from cancer to viral entry, yet fundamental aspects of its biosynthesis remain incompletely understood. Here, the binding preferences of the uronyl 2-O-sulfotransferase (HS2ST) are examined with variably-sulfated hexasaccharides. Surprisingly, heavily sulfated oligosaccharides formed by later-acting sulfotransferases bind more tightly to HS2ST than those corresponding to its natural substrate or product. Inhibition assays also indicate that the IC(50) values correlate simply with degree of oligosaccharide sulfation. Structural analysis predicts a mode of inhibition in which 6-O-sulfate groups located on glucosamine residues present in highly-sulfated oligosaccharides occupy the canonical binding site of the nucleotide cofactor. The unexpected finding that oligosaccharides associated with later stages in HS biosynthesis inhibit HS2ST indicates that the enzyme must be separated temporally and/or spatially from downstream products during biosynthesis in vivo, and highlights a challenge for the enzymatic synthesis of lengthy HS chains in vitro. Nature Publishing Group UK 2018-08-07 /pmc/articles/PMC6081452/ /pubmed/30087361 http://dx.doi.org/10.1038/s41598-018-29602-4 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Thieker, David F. Xu, Yongmei Chapla, Digantkumar Nora, Chelsea Qiu, Hong Felix, Thomas Wang, Lianchun Moremen, Kelley W. Liu, Jian Esko, Jeffrey D. Woods, Robert J. Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase |
title | Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase |
title_full | Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase |
title_fullStr | Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase |
title_full_unstemmed | Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase |
title_short | Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase |
title_sort | downstream products are potent inhibitors of the heparan sulfate 2-o-sulfotransferase |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081452/ https://www.ncbi.nlm.nih.gov/pubmed/30087361 http://dx.doi.org/10.1038/s41598-018-29602-4 |
work_keys_str_mv | AT thiekerdavidf downstreamproductsarepotentinhibitorsoftheheparansulfate2osulfotransferase AT xuyongmei downstreamproductsarepotentinhibitorsoftheheparansulfate2osulfotransferase AT chapladigantkumar downstreamproductsarepotentinhibitorsoftheheparansulfate2osulfotransferase AT norachelsea downstreamproductsarepotentinhibitorsoftheheparansulfate2osulfotransferase AT qiuhong downstreamproductsarepotentinhibitorsoftheheparansulfate2osulfotransferase AT felixthomas downstreamproductsarepotentinhibitorsoftheheparansulfate2osulfotransferase AT wanglianchun downstreamproductsarepotentinhibitorsoftheheparansulfate2osulfotransferase AT moremenkelleyw downstreamproductsarepotentinhibitorsoftheheparansulfate2osulfotransferase AT liujian downstreamproductsarepotentinhibitorsoftheheparansulfate2osulfotransferase AT eskojeffreyd downstreamproductsarepotentinhibitorsoftheheparansulfate2osulfotransferase AT woodsrobertj downstreamproductsarepotentinhibitorsoftheheparansulfate2osulfotransferase |